A detailed history of Ambassador Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Ambassador Advisors, LLC holds 901 shares of AMGN stock, worth $265,371. This represents 0.05% of its overall portfolio holdings.

Number of Shares
901
Previous 914 1.42%
Holding current value
$265,371
Previous $285,000 1.75%
% of portfolio
0.05%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $4,021 - $4,385
-13 Reduced 1.42%
901 $290,000
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $6,306 - $7,663
-24 Reduced 2.56%
914 $285,000
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $252,200 - $304,437
938 New
938 $266,000
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $480,932 - $586,176
2,130 New
2,130 $514,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Ambassador Advisors, LLC Portfolio

Follow Ambassador Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ambassador Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ambassador Advisors, LLC with notifications on news.